Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Sell
5Bullish
5Neutral
12Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Adaptimmune Therapeutics is a Buy.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 0.25, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 0.28, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics (ADAP) Pivot Points
Classic
0.21
0.22
0.22
0.24
0.24
0.25
0.26
Fibonacci
0.22
0.22
0.23
0.24
0.24
0.25
0.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAP) Moving Averages
MA5
0.24Buy
0.24Buy
MA10
0.24Sell
0.24Sell
MA20
0.25Sell
0.25Sell
MA50
0.27Sell
0.28Sell
MA100
0.34Sell
0.36Sell
MA200
0.53Sell
0.57Sell
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 0.24, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 0.36, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 0.27, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 0.34, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.53, creating a Sell signal.
Adaptimmune Therapeutics (ADAP) Technical Indicators
RSI (14)
41.57
Neutral
STOCH (9,6)
26.72
Neutral
STOCHRSI (14)
21.87
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
19.08
Buy
Williams %R
-68.75
Buy
CCI (14)
-90.92
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
42.19
Neutral
ROC
-11.11
Sell
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 41.57, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 19.08, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is -90.92, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is -11.11, creating a Sell signal.
FAQ
Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Sell.
What is ADAP’s RSI (14)?
ADAP’s RSI (14) is 41.57, which suggests ADAP is a Neutral.
What is ADAP’s MACD?
ADAP’s MACD is -0.01, which suggests ADAP is a Buy.
What is ADAP’s 5-day moving average?
ADAP’s 5-day moving average is 0.24, which suggests ADAP is a Buy.
What is ADAP’s 20-day moving average?
ADAP 20-day moving average is 0.25, which suggests ADAP is a Sell.
What is ADAP’s 50-day moving average?
ADAP’s 50-day moving average is 0.27, which suggests ADAP is a Sell.
What is ADAP’s 200-day moving average?
ADAP’s 200-day moving average is 0.53, which suggests ADAP is a Sell.
What is ADAP’s Williams % R (14)?
ADAP’s Williams % R (14) is -68.75, which suggests ADAP is a Buy.
What is ADAP’s CCI (14)?
ADAP’s CCI (14) is -90.92, which suggests ADAP is a Neutral.